EE200000694A - Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon - Google Patents

Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon

Info

Publication number
EE200000694A
EE200000694A EEP200000694A EEP200000694A EE200000694A EE 200000694 A EE200000694 A EE 200000694A EE P200000694 A EEP200000694 A EE P200000694A EE P200000694 A EEP200000694 A EE P200000694A EE 200000694 A EE200000694 A EE 200000694A
Authority
EE
Estonia
Prior art keywords
iterferon
ifn
beta
formulation
recombinant human
Prior art date
Application number
EEP200000694A
Other languages
English (en)
Estonian (et)
Inventor
Alam John
Rogge Mark
Goelz Susan
Original Assignee
Biogen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc. filed Critical Biogen, Inc.
Publication of EE200000694A publication Critical patent/EE200000694A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200000694A 1998-05-29 1998-05-29 Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon EE200000694A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/007242 WO1999062542A1 (en) 1998-05-29 1998-05-29 Recombinant human interferon beta-1a (ifn-beta-1a) formulation

Publications (1)

Publication Number Publication Date
EE200000694A true EE200000694A (et) 2002-06-17

Family

ID=22266817

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000694A EE200000694A (et) 1998-05-29 1998-05-29 Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon

Country Status (16)

Country Link
EP (1) EP1082132A1 (hu)
JP (1) JP2002516874A (hu)
KR (1) KR20010052454A (hu)
CN (1) CN1299285A (hu)
AU (1) AU8822598A (hu)
BR (1) BR9815966A (hu)
CA (1) CA2333063A1 (hu)
EA (1) EA200001252A1 (hu)
EE (1) EE200000694A (hu)
HU (1) HUP0102241A2 (hu)
IL (1) IL139933A0 (hu)
IS (1) IS5732A (hu)
NO (1) NO20006022L (hu)
SK (1) SK17762000A3 (hu)
TR (1) TR200003521T2 (hu)
WO (1) WO1999062542A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
ATE370729T1 (de) * 2000-12-21 2007-09-15 Resuscitation Technologies Llc Stabile t3 zusammensetzungen und ihre anwendung
CN1325651C (zh) * 2001-05-24 2007-07-11 大连金威基因技术有限公司 人重组乙型干扰素的高效表达及其应用
CN1535724B (zh) * 2003-04-23 2012-09-05 北京金迪克生物技术研究所 重组人干扰素在制备预防严重性急性呼吸道综合征的药物的用途
ES2638977T3 (es) * 2007-12-04 2017-10-24 Biogen Chesapeake Llc Formulaciones y procedimientos mejorados para liofilización y liofilizados obtenidos por los mismos
US20230348566A1 (en) * 2020-09-12 2023-11-02 Academia Sinica Re-folded human serum albumin and use thereof for anti-tumor

Also Published As

Publication number Publication date
HUP0102241A2 (hu) 2001-10-28
WO1999062542A1 (en) 1999-12-09
SK17762000A3 (sk) 2001-07-10
EP1082132A1 (en) 2001-03-14
CN1299285A (zh) 2001-06-13
KR20010052454A (ko) 2001-06-25
IL139933A0 (en) 2002-02-10
AU8822598A (en) 1999-12-20
BR9815966A (pt) 2001-02-28
JP2002516874A (ja) 2002-06-11
NO20006022L (no) 2001-01-26
CA2333063A1 (en) 1999-12-09
IS5732A (is) 2000-11-24
NO20006022D0 (no) 2000-11-28
TR200003521T2 (tr) 2001-07-23
EA200001252A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
ATE176383T1 (de) Dermal applizierbare formulierungen von parasitiziden
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
IS2325B (is) Örgerðar samsetningar epleróns
NO20004540D0 (no) Sammensetninger av peptider, formuleringer og anvendelse derav
NO983364L (no) Konsensusproteiner
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
IS5191A (is) Örverueyðandi hindrun og meðferð gegn eyðniveirunni og öðrum smitsjúkdómum í mönnum
DE69900746D1 (de) Gesteuerte verabreichung von peptiden oder proteinen
BR9800344A (pt) Composição de vidro e utilização das composições de vidro
ID22878A (id) Komposisi aktif secara terapi
CY2006006I2 (el) Πρωτεϊνικα σκευασματα
DE69826451D1 (de) Anästehischer knochenzement
ID26999A (id) Komposisi perawatan kulit
DE69719083D1 (de) Neuartige orale Zubereitungen von Calcitonin
ATE297761T1 (de) Zubereitungen zur stabilisierung von peg- interferon alpha konjugaten
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
ID21725A (id) Kompresor jenis piringan hentak
NO20000575D0 (no) Rekombinant ekspresjon av insulin C-peptid
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
DE69822559D1 (de) Siliconzusammensetzung
PT1222921E (pt) Composicoes farmaceuticas de tizoxanida e nitazoxanida
DE69837507D1 (de) Humanes Hedgehog-Protein
DE69903553D1 (de) Verkapselung wasserlöslicher peptide
DE69832127D1 (de) Wässrige Siliconzusammensetzung